RETATRUETIDE

🧪 Product Description

This 20mg vial contains Retatrutide, a long-acting triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. Provided as a sterile, lyophilized powder, it offers excellent stability and ease of handling for research environments.

Retatrutide is being actively studied for its potential impact on body weight regulation, insulin sensitivity, and metabolic balance, positioning it as a next-gen tool in the field of incretin-based peptide research.

🔍 Key Features

✅ 20mg per vial – ideal for extended or high-dose research protocols
✅ Lyophilized powder – stable and easy to reconstitute
✅ Triple receptor agonist – GLP-1 / GIP / Glucagon pathway activation
✅ Molecular Weight: 4261.76 g/mol (C187H296N52O60)
✅ Third-party lab tested – ≥99% purity verified
✅ View COA

⚠️ For research use only. Not for human consumption, medical, or veterinary use.